The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immune checkpoint inhibitors (ICIs) in gastrointestinal (GI) cancer: Immune-related adverse events (IRAEs) and efficacy.
 
Satya Das
Honoraria - Targeted Oncology
 
Kristen Keon Ciombor
Consulting or Advisory Role - Bayer; Foundation Medicine; Research to Practice
Research Funding - Amgen (Inst); Array BioPharma (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Incyte (Inst); Incyte (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Nucana (Inst); Onyx (Inst); Pfizer (Inst); Sanofi (Inst)
 
Sigurdis Haraldsdottir
No Relationships to Disclose
 
Yoanna S Pumpalova
No Relationships to Disclose
 
Ibrahim Halil Sahin
No Relationships to Disclose
 
Yu Shyr
Consulting or Advisory Role - Aduro Biotech; GlaxoSmithKline; Janssen Research & Development; Novartis; Pfizer; Roche/Genentech
 
Shih-Kai Chu
No Relationships to Disclose
 
Emily Pei-Ying Lin
No Relationships to Disclose
 
Chih-Yuan Hsu
No Relationships to Disclose
 
Laura Williams Goff
Consulting or Advisory Role - Bayer/Onyx; Competitive Drug Development International; Eisai; Lilly; Newlink Genetics
Research Funding - Agios; ArQule; ASLAN Pharmaceuticals; Astellas Pharma; BeiGene; Bristol-Myers Squibb; H3 Biomedicine; Incyte; Leap Therapeutics; Lilly; Onyx; Pfizer; Sun Pharma
 
Dana Backlund Cardin
Consulting or Advisory Role - Abbvie; Rafael Pharmaceuticals
Research Funding - Advaxis (Inst); Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); EMD Serono (Inst); Incyte (Inst); Lilly (Inst); Synta (Inst)
Travel, Accommodations, Expenses - Abbvie
 
Mehmet Asim Bilen
Consulting or Advisory Role - Exelixis; Nektar; Sanofi
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Incyte (Inst); Nektar (Inst); Peleton (Inst); Pfizer (Inst); Seagen (Inst); Tricon Pharmaceuticals (Inst)
 
Jordan Berlin
Honoraria - Nestle health science
Consulting or Advisory Role - Abbvie; Arno Therapeutics; AstraZeneca; Bayer Health; BeiGene; Celgene; Cornerstone Pharmaceuticals; Eisai; EMD Serono; ERYTECH Pharma; Exelixis; Five Prime Therapeutics; Genentech/Roche; Gritstone Bio; Karyopharm Therapeutics; lsk biopharma; Seagen
Research Funding - Bayer (Inst); BeiGene (Inst); boston biomedical (Inst); EMD Serono (Inst); Five Prime Therapeutics (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Immunomedics (Inst); Incyte (Inst); Karyopharm Therapeutics (Inst); Loxo (Inst); Macrogenics (Inst); Pharmacyclics (Inst); Symphogen (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Abbvie; Bayer; EMD Serono; Nestle health science; Seagen
Other Relationship - AstraZeneca
 
Christina Wu
Research Funding - Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Lycera (Inst); Seagen (Inst); Symphogen (Inst); Vaccinex (Inst)